Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

ESSA Pharma Inc

EPIX
1,64
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 09:02:04
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/3/202510:45PRNUSContact The Gross Law Firm by March 25, 2025 Deadline to..
06/3/202513:02EDGAR2Form 8-K - Current report
06/3/202513:00PRNCAESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING..
06/3/202511:45PRNUSESSA Pharma Inc. Class Action: The Gross Law Firm Reminds..
27/2/202511:45PRNUSThe Gross Law Firm Notifies Shareholders of ESSA Pharma..
24/2/202511:45PRNUSShareholders of ESSA Pharma Inc. Should Contact The Gross..
20/2/202511:45PRNUSInvestors who lost money on ESSA Pharma Inc.(EPIX) should..
13/2/202511:45PRNUSClass Action Filed Against ESSA Pharma Inc. (EPIX) Seeking..
11/2/202522:00EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
11/2/202513:02EDGAR2Form 8-K - Current report
11/2/202513:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/2/202513:00PRNUSESSA Pharma Reports Financial Results for Fiscal First..
10/2/202511:45PRNUSClass Action Filed Against ESSA Pharma Inc. (EPIX) - March..
03/2/202511:45PRNUSMarch 25, 2025 Deadline: Contact The Gross Law Firm to Join..
30/1/202511:45PRNUSShareholders of ESSA Pharma Inc. Should Contact The Gross..
22/1/202522:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/1/202522:15EDGAR2Form DEF 14A - Other definitive proxy statements
17/12/202413:02EDGAR2Form 8-K - Current report
17/12/202413:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
17/12/202413:00PRNUSESSA Pharma Provides Corporate Update and Reports Financial..
06/12/202413:00EDGAR2Form 8-K - Current report
01/11/202421:30EDGAR2Form 8-K - Current report
01/11/202401:57PRNUSESSA Pharma Announces Termination of Phase 2 Study..
07/10/202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202423:19PRNCAESSA Pharma Presents Updated Phase 1/2 Masofaniten..
11/9/202422:05PRNUSESSA Pharma to Present at the 2024 Cantor Global Healthcare..
09/9/202420:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202422:17EDGAR2Form 144 - Report of proposed sale of securities
05/8/202413:01EDGAR2Form 8-K - Current report
05/8/202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202413:00PRNUSESSA Pharma Provides Corporate Update and Reports Financial..
08/7/202422:05PRNCAESSA Pharma to Present at the JonesHealthcare Seaside Summit
30/5/202414:00PRNCAESSA Pharma to Present at the Jefferies Global Healthcare..
14/5/202413:01EDGAR2Form 8-K - Current report
14/5/202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202413:00PRNUSESSA Pharma Provides Corporate Update and Reports Financial..
06/5/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/4/202414:00PRNUSESSA Pharma to Present at the 2024 Bloom Burton & Co...
Apertura: Min: Max:
Chiusura: 1,64

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network